Delivery Order SPE2DB22D3009-SPE2DB25FAK39
Award Date
11/22/24
Potential Completion Date
11/25/24
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,584.38, is for the delivery of 4567410604 MOXIFLOXACIN HCL 400 MG TABLET 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of February 28, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOXIFLOXACIN HCL 400 MG TABLET UD 50S, a pharmaceutical product, with a total ceiling value of $3,250.65. The contract is a firm-fixed-price, non-set-aside award, with an ultimate completion date of July 2, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,561.19 firm fixed-price delivery order is for the supply of Moxifloxacin HCL 400 mg tablets, a medication used to treat bacterial infections. The contract has an ultimate completion date of June 25, 2025 and is not set aside for any specific business designation. Amerisourcebergen Drug Corp holds a significant...
This is a $2,070.00 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of MOXIFLOXACIN HCL 400 MG TABLET UD 50S. The contract is a firm fixed-price delivery order with a completion date of June 30, 2025. The award was made on June 27, 2025 and is not set-aside. Amerisourcebergen Drug Corp is a for-profit organization registered in SAM.gov and has an extensive history of providing pharmaceutical and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,285.44 firm fixed-price delivery order is for the supply of 4,568,092,674 units of the antibiotic medication Moxifloxacin Hydrochloride 400 mg Tablets. The award is not set aside and is part of a larger indefinite delivery contract (IDC) valued at $999,999,999.00 held by AmerisourceBergen with DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,760.00 firm fixed-price delivery order is for the supply of 50 units of 400 mg moxifloxacin HCl tablets, with a completion date of June 26, 2025. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) vehicle with the DLA Troop Support Medical, which provides...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOXIFLOXACIN HCL 400 MG TABLET 30S, with a ceiling value of $1,469.75 and a period of performance through June 17, 2025. The contract is not set aside and represents open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $1,940.89 for the supply of 4568252897 - MOXIFLOXACIN 400 MG/250 ML BAG 250ML, a pharmaceutical product. The contract is not set aside and is a firm fixed-price delivery order with a completion date of May 15, 2025....
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of 4,565,350 units of the pharmaceutical product Moxifloxacin HCL 400 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has a firm fixed price of $1,290.39. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $59,726.47 firm fixed-price delivery order is for the supply of 4,565,213,771 units of Moxifloxacin HCL 400 mg tablets. The contract has an ultimate completion date of July 23, 2024 and was awarded on July 22, 2024 with no set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite...